Short Description

NGS genetic DNA test detecets for variant and mutation detection in RET gene for Multiple endocrine neoplasia type 2A

PreTest Information

Clinical History of Patient who is going for RET Gene Multiple endocrine neoplasia type 2A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RET Gene Multiple endocrine neoplasia type 2A NGS Genetic DNA Test gene RET

Detail Description

RET Gene Multiple Endocrine Neoplasia Type 2A NGS Genetic DNA Test Cost INR 20000

Multiple endocrine neoplasia type 2A (MEN2A) is a rare genetic disorder that affects the endocrine system. It is caused by mutations in the RET gene, which is responsible for producing a protein that helps regulate cell growth and division. MEN2A is characterized by the development of tumors in the thyroid gland, adrenal gland, and parathyroid gland.

NGS (next-generation sequencing) is a powerful genetic testing technology that can be used to identify mutations in the RET gene. This test can help diagnose MEN2A and provide important information about the risk of developing tumors in affected individuals and their family members.

Symptoms of MEN2A

The symptoms of MEN2A can vary depending on the specific mutations present in the RET gene. Some common symptoms include:

• Development of thyroid nodules or tumors
• High blood calcium levels (hypercalcemia)
• High blood pressure
• Adrenal gland tumors
• Abnormal growth of bones and other tissues

It is important to note that not all individuals with MEN2A will experience these symptoms, and some individuals may develop tumors in other parts of the body as well.

Diagnosis of MEN2A

The diagnosis of MEN2A typically involves a combination of clinical evaluation, genetic testing, and imaging studies. If a healthcare provider suspects that an individual may have MEN2A based on their symptoms and medical history, they may recommend genetic testing to confirm the diagnosis.

NGS genetic testing is a highly accurate and reliable method for identifying mutations in the RET gene. This test can be performed using a blood or saliva sample, and results are typically available within a few weeks.

Cost of MEN2A NGS Genetic DNA Test in India

The cost of MEN2A NGS genetic testing in India can vary depending on the specific testing facility and location. However, on average, the cost of this test is around INR 20,000.

It is important to note that some insurance companies may cover the cost of genetic testing for individuals with a suspected or confirmed diagnosis of MEN2A. It is recommended that individuals check with their insurance provider to determine if genetic testing is covered under their plan.

Conclusion

MEN2A is a rare genetic disorder that can cause tumors in the thyroid gland, adrenal gland, and parathyroid gland. NGS genetic testing can be used to identify mutations in the RET gene and provide important information about an individual's risk of developing tumors. The cost of MEN2A NGS genetic testing in India is around INR 20,000, and individuals should check with their insurance provider to determine if the cost of testing is covered under their plan.

Early diagnosis and management of MEN2A can help improve outcomes and reduce the risk of complications. If you or a loved one is experiencing symptoms of MEN2A, it is important to speak with a healthcare provider as soon as possible to determine the appropriate course of treatment.

For more information about MEN2A NGS genetic testing in India, please contact DNA Labs India.

Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for RET Gene Multiple endocrine neoplasia type 2A NGS Genetic DNA Test